Modal Title
Course Description
This course reviews key concepts related to the tick lifespan, various types of ticks, and their disease transmission. The location for certain ticks in the United States will be reviewed. Specific tickborne diseases, their transmission, presentation, diagnosis, and treatment will be discussed in detail. The student will learn key concepts in tickborne disease prevention.
Intended Audience
All healthcare providers
Learning Objectives
At the completion of this activity, healthcare providers will be able to:
- Describe ticks that are endemic to a particular geographic region.
- Compare the pathogenesis of select tick-borne diseases
- Describe the presentation, symptoms, management, and treatment of several tickborne diseases
- Identify key concepts in patient education and tick-borne disease prevention
At the completion of this activity, assistants, aids, support staff, and pharmacy technicians will be able to:
- Explain tick-bite prevention strategies
Details
- Credit/Contact Hours
- 1
- Pharmacotherapy Hours
- 0.5
- Faculty
-
- Megan Arbour, PhD, RN, CNM, CNE
Associate Professor, Frontier Nursing University
- Megan Arbour, PhD, RN, CNM, CNE
- Language
-
- English
- Release Date
- February 1, 2023
- Expiration Date
- February 1, 2026
- Instructional Methods
-
- Assessment Review with Rationale
- Case Studies
- Ungraded Self Assessment-Lesson Recall
- Video Clips
- Video Narration
- Assessment
-
- Autograded and Quiz Retakes Allowed
- Daily CE Broker Reporting for Registered Boards
- Graded Final Quiz
- Passing 80%+
State/Local Approvals
- Approved/Accepted By
-
- Alabama State Board of Occupational Therapy
- Arizona Board of Occupational Therapy Examiners
- Arkansas State Board of Nursing
- Bahamas Medical Council
- District of Columbia Board of Nursing
- Florida Board of Dentistry
- Florida Board of Medicine
- Florida Board of Nursing
- Florida Board of Nursing - Certified Nursing Assistants
- Florida Board of Occupational Therapy
- Florida Board of Osteopathic Medicine
- Florida Board of Pharmacy
- Florida Council of Licensed Midwifery
- Florida Office of Dental Laboratories
- Florida Physician Assistants
- Georgia Board of Nursing
- Georgia Composite Medical Board - Acupuncturists
- Georgia Composite Medical Board - Physician Assistants
- Georgia Composite Medical Board - Physicians & Telemedicine
- Georgia State Board of Occupational Therapy
- Kansas State Board of Nursing
- Kentucky Board of Nursing
- Louisiana State Board of Medical Examiners - Physicians & Surgeons
- Michigan Board of Nursing
- Michigan Board of Pharmacy
- Mississippi Board of Nursing
- Mississippi State Board of Medical Licensure
- New Hampshire Medical Society
- New Mexico Board of Nursing
- New Mexico Medical Board
- North Dakota Board of Nursing
- Oklahoma Board of Medical Licensure and Supervision - Medical Doctors
- Oklahoma Board of Medical Licensure and Supervision - Physician Assistants
- South Carolina Board of Medical Examiners
- South Carolina Board of Nursing
- State Medical Board of Ohio
- Tennessee Board of Dentistry
- Tennessee Board of Medical Examiners
- Tennessee Board of Osteopathic Examination
- West Virginia Board of Registered Nurses
- Wyoming Board of Nursing
CE Accreditation
- Accrediting CEs
-
Jointly provided by Partners for Advancing Clinical Education (PACE) and Premiere Education.
In support of improving patient care, this activity has been planned and implemented by Partners for Advancing Clinical Education (PACE) and Premiere Education. PACE is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Nursing Continuing Professional Development
The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 1 contact hour(s).
Designated for 0.5 contact hour(s) of pharmacotherapy credit for Advance Practice Registered Nurses.Physician Continuing Education
PACE designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Pharmacy Continuing Education
PACE designates this continuing education activity for 1 contact hour(s) (0.1 CEUs) of the Accreditation Council for Pharmacy Education.
Universal Activity Number - JA4008073-9999-22-278-H01-P
Universal Activity Number - JA4008073-9999-22-278-H01-T
Type of Activity: KnowledgeUpon successfully completing the post-test with a score of 80% or better and the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 4 weeks.
- Instructions for CE Credit
-
Participation in this self-study activity should be completed in approximately 1 hour(s). To successfully complete this activity and receive CE credit, learners must follow these steps during the period from February 1, 2023 through February 1, 2026:
- Review objectives and disclosures
- Study the educational content
- Successfully complete activity assessment(s)
- Complete the activity evaluation
You must receive an assessment score of at least 80% and respond to all evaluation questions to receive a certificate.
Disclosures
- Disclosures
-
Disclosure of Conflicts of Interest
PACE requires planners, faculty, and other individuals who are in a position to control the content of this activity to disclose all financial relationships they may have with ineligible companies. All relevant financial relationships are thoroughly vetted and mitigated according to PACE policy. PACE is committed to providing learners with high-quality accredited CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.
Faculty: The faculty reported the following financial relationships or relationships to products or devices they have with ineligible companies:
-
Megan Arbour, PhD, RN, CNM, CNE
Associate Professor, Frontier Nursing University
• has no relevant financial relationships with ineligible companies to disclose
Planners & Managers & Translators: The PACE & Premiere Education planners and others have no relevant financial relationship(s) to disclose with ineligible companies.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
-
Megan Arbour, PhD, RN, CNM, CNE